Company Overview of LXRepair SAS
LXRepair SAS develops assay tests for enzymatic DNA repair activities to optimize the discovery of new drugs and to customize therapeutic behavior in oncology. It develops Companion Diagnostic kits to help clinicians to optimize radiotherapy or chemotherapy treatments to fight cancer. The company was founded in 2013 and is headquartered in Grenoble, France.
7, parvis Louis Néel
Founded in 2013
33 4 38 78 37 52
Key Executives for LXRepair SAS
Similar Private Companies By Industry
|Acticor Biotech SAS||Europe|
|Aelis Farma S.A.S.||Europe|
|Aenitis Technologies SAS||Europe|
Recent Private Companies Transactions
September 6, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact LXRepair SAS, please visit www.lxrepair.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.